TradingKey - P3 Health Partners is at $12.38 after pulling back from $18.52 post-earnings high. Ascending trendline from $5.91 intact. Q1 net income +$3M vs -$44M prior year. EBITDA $26M. Target $14.16.

TradingKeySat, May 30

P3 Health Partners Swung to Profit and Beat EPS by $5.17 — Is PIII Stock a Buy at $10?

TradingKey - P3 Health Partners Q1 2026: EPS +$0.32 vs -$4.85 estimate. Medical margin jumped from $49 to $231 per member. 2026 EBITDA guidance raised to $20–$60M. Lake Street target raised to $14. PIII at $10.

TradingKeyWed, May 20